Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The article on “Neutrophilic Urticaria With Systemic Inflammation: A Case Series” by Belani et al1 was published because we believed that our readers were unfamiliar with this concept. Additionally, the approach of treating with interleukin 1 antagonists is relatively underappreciated in the dermatologic community. Lipsker et al2 had previously noted this issue under a different nomenclature, neutrophilic urticarial dermatosis.2 While we recognize the concept that both groups are describing the same disease, we believe that the name proposed by Belani et al more accurately reflects the need to consider systemic disease than that proposed previously.
Callen JP, Robinson JK. The Importance of a Name. JAMA Dermatol. 2013;149(10):1245. doi:10.1001/jamadermatol.2013.5483